Pacer Advisors, Inc. Neoleukin Therapeutics, Inc. Transaction History

Pacer Advisors, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$9.23 - $13.12 $15,017 - $21,346	-1,627 Closed	0 $0
Q1 2021 Apr 05, 2021	BUY	$11.26 - $15.78 $3,242 - $4,544	288 Added 21.51%	1,627 $20,000
Q4 2020 Jan 20, 2021	BUY	$10.17 - $14.56 $13,617 - $19,495	1,339 New	1,339 $19,000

199K

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.